Center for Biosecurity Publications Archive

2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998

2008

• "Preventing and Deterring Biological Attacks: Priorities that Should Emerge from the WMD Commission Report." The Center's comments about the WMD Commission's "World at Risk" report, December 2008. 
• Commentary: "What Role Can Alternative Care Facilities Play in an Influenza Pandemic?" Waldhorn R. Biosecurity and Bioterrorism. 2008;6(4):357-358. 
• "Scientists Urge DHS to Improve Bioterrorism Risk Assessment." Parnell GS, Borio LL, Brown GG, et al. Biosecurity and Bioterrorism. 2008;6(4):353-356. 
• "Improving the Select Agent Program." Gronvall GK. Bulletin of the Atomic Scientists. October 29, 2008. http://www.thebulletin.org/web-edition/features/improving-the-select-agent-program. 
• "Comments from the Center for Biosecurity of UPMC on Draft Guidances for Pandemic Influenza Planning." Mair M, Norwood A, Courtney B and Nuzzo J. Biosecurity and Bioterrorism. 2008;6(3):279-284. 
• "Community Resilience Roundtable on the Implementation of Homeland Security Presidential Directive 21 (HSPD-21)." Schoch-Spana M, Courtney B, Franco C, et al. Biosecurity and Bioterrorism. 2008;6(3):269-278. 
• "Cost/Success Projections for US Biodefense Countermeasure Development." Matheny J, Mair M, and Smith B. Nature Biotechnology. 2008;26(9):981-983. 
• Editorial: "Community Resilience for Catastrophic Health Events." Schoch-Spana M. Biosecurity and Bioterrorism. 2008;6(2):129-130. 
• "Billions for Biodefense: Federal Agency Biodefense Funding, FY2008-FY2009." Franco C. Biosecurity and Bioterrorism. 2008;6(2):131-146. 
• "Panalysis: A New Spreadsheet-Based Tool for Pandemic Planning." Abramovich M, Toner E, and Matheny J. Biosecurity and Bioterrorism. 2008;6(1):78-92. 
• "Healthcare Epidemiology: The Current Status of Planning for Pandemic Influenza and Implications for Health Care Planning in the United States." Bartlett JG and Borio L. Clinical Infectious Diseases. 2008;46(6):919-925. 
• "Biodefense Countermeasures: The Impact of Title IV of the US Pandemic and All-Hazards Preparedness Act." Gronvall GK. Emerging Health Threats Journal. 2008;1:e3. doi: 10.3134/ehtj.08.003. 
• Roundtable On-line Discussion: "Is the Availability of Genetic Information Dangerous?" Gronvall GK, Kuhn J, Hunger I and Ryabikhin LF. Bulletin of Atomic Scientists 8 November 2007 to 28 February 2008. http://www.thebulletin.org/web-edition/roundtables/is-the-availability-genetic-information-dangerous. 
• "Avian Influenza: Critical Program Issues." Yansen S, Safi B, Nuzzo J, and Barnett D. Global Health Technical Brief (Prepared for the United States Agency for International Development). February 2008. 
• "Handcuffing the Flu: Can a Law Enforcement/National Security Approach to Pandemic Preparedness Protect the American People?" Schoch-Spana M. Remarks delivered Jan 14, 2008 , to mark the release of the ACLU's report: Pandemic Preparedness: The Need for a Public Health—Not a Law Enforcement/National Security–Approach, by George J. Annas, Wendy K. Mariner and Wendy E. Parmet. 

2007

• "The National Disaster Medical System: Past, Present, and Suggestions for the Future." Franco C, Toner E, Waldhorn R, et al. Biosecurity and Bioterrorism. 2007;5(4):319-326. 
• "Financial Effects of an Influenza Pandemic on U.S. Hospitals." Matheny J, Toner E, and Waldhorn R. Journal of Health Care Finance. 2007;34(1):58–63. 
• "Summary of HSPD-21." Mair M and Franco C, October 2007. 
• "Reducing the Risk of Human Extinction." Matheny J. Risk Analysis. 2007;27(5). 
• "Letter to Editor: The FDA Animal Efficacy Rule and Biodefense." Gronvall GK, Trent D, Borio L, et al. Nature Biotechnology. 2007;25:1084-1087. 
• "Flexible Defenses Roundtable Meeting: Promoting the Strategic Innovation of Medical Countermeasures." Gronvall GK, Matheny J, Smith B, et al. Biosecurity and Bioterrorism. 2007;5(3):271-277. 
• "Incentives for Biodefense Countermeasure Development." Matheny J, Mair M, Mulcahy A and Smith B. Biosecurity and Bioterrorism. 2007;5(3):228-238. 
• "Challenges to Global Surveillance and Response to Infectious Disease Outbreaks of International Importance." Hitchcock P, Chamberlain A, Van Wagoner M, et al. Biosecurity and Bioterrorism. 2007;5(3):206-227. 
• "Immune-Boosting Adjuvants." Chamberlain A and Gronvall GW. Biosecurity and Bioterrorism. 2007;5(3):202-205. 
• "Billions for Biodefense: Federal Agency Biodefense Funding, FY2007-FY2008." Franco C and Deitch S. Biosecurity and Bioterrorism. 2007;5(2):117-133. 
• "Biomedical Advanced Research and Development Authority (BARDA) Roundtable." Gronval GK, Smith B, Matheny J, et al. Biosecurity and Bioterrorism. 2007;5(2):174-179. 
• "Roundtable: Promoting Partnerships for Regional Healthcare Preparedness and Response." Maldin-Morgenthau B, Toner E, Waldhorn R, et al. Biosecurity and Bioterrorism. 2007;5(2):180-185. 
• "Roundtable Discussion: Corporate Pandemic Preparedness." Maldin-Morgenthau B, Toner E, Wilkinson D, et al. Biosecurity and Bioterrorism. 2007;5(2):168-173. 
• "The Science of Biodefense: RNAi." Chamberlain A and Gronvall GK. Biosecurity and Bioterrorism. 2007;5(2):104-106. 
• "Public Archetypes in U.S. Counter-Bioterrorist Policy." Schoch-Spana M. In Durmaz H et al. eds. Understanding and Responding to Terrorism. NATO Security through Science Series, E: Human and Societal Dynamics. Amsterdam, Netherlands: IOS Press; 2007:Vol. 19. pp. 364-374. 
• "Regional Approaches to Hospital Preparedness." Maldin B, Lam C, Franco C, et al. Biosecurity and Bioterrorism. 2007;5(1):43-54. 
• "Community Engagement: Leadership Tool for Catastrophic Health Events." Schoch-Spana M, Franco C, Nuzzo J, and Usenza C. Biosecurity and Bioterrorism. 2007;5(1):8-25. 
• "Meeting Report: High-Containment Biodefense Research Laboratories: Meeting Report and Center Recommendations." Gronvall GK, Fitzgerald J, Chamberlain A, et al. Biosecurity and Bioterrorism. 2007;5(1):75-85. 
• "Commentary on Community Mitigation of Pandemic Influenza." Toner E. eInfluenza Review. 2007;1(6). 
• Issue Brief: "Global Biotechnology and Pharmaceutical Industries," Matheny J, January 2007. 

2006

• "Prepared Statement: Passage of S. 3678-The Pandemic and All-Hazards Preparedness Act." Mair M, Maldin B, and Smith B. December 20, 2006. Summary of S. 3678: The Pandemic and All-Hazards Preparedness Act. 
• "The Prospect of Using Alternative Medical Care Facilities in an Influenza Pandemic." Lam C, Waldhorn R, Toner E, et al. Biosecurity and Bioterrorism. 2006;4(4):384-390. 
• "What Hospitals Should Do to Prepare for an Influenza Pandemic." Toner E and Waldhorn R. Biosecurity and Bioterrorism. 2006;4(4):397-402. 
• "Statement to the 6th Review Conference of the BWC." Delivered by Gigi Kwik Gronvall, Senior Associate, Center for Biosecurity, November 2006. 
• "Book Review: Safe Food: Bacteria, Biotechnology, and Bioterrorism." Schoch-Spana M. Agricultural History. 2006;80(4). 
• "Disease Mitigation in the Control of Pandemic Influenza." Inglesby TV, Nuzzo J, O'Toole T, and Henderson DA. Biosecurity and Bioterrorism. 2006;4(4):366-375. 
• "Risky Business: Planning for Pandemic Flu." Maldin B and Criss K. Biosecurity and Bioterrorism. 2006;4(3):307-312. 
• "Disease, Disaster, and Democracy: The Public's Stake in Health Emergency Planning." Schoch-Spana M, Chamberlain A, Franco C, et al. Biosecurity and Bioterrorism. 2006;4(3):313-319. 
• "Comments from the Center for Biosecurity of UPMC on the National Strategy for Pandemic Influenza: Implementation Plan." By Center Staff. Biosecurity and Bioterrorism. 2006;4(3):320-324. 
• "Hospital Preparedness for Pandemic Influenza." Toner E, Waldhorn R, Maldin B, et al. Biosecurity and Bioterrorism. 2006;4(2):207-217. 
• "Comments from the Center for Biosecurity of UPMC on Proposed Revisions to Federal Quarantine Rules." Nuzzo J, Henderson DA, O'Toole T, and Inglesby TV. Biosecurity and Bioterrorism. 2006;4(2):204-206. 
• "Positive-Pressure Ventilation Equipment for Mass Casualty Respiratory Failure." Rubinson L, Branson RD, Pesik N, and Talmors D. Biosecurity and Bioterrorism. 2006;4(2):183-194. 
• "Getting Medicine to Millions: New Strategies for Mass Distribution." Lien O, Maldin B, Franco C, and Gronvall GK. Biosecurity and Bioterrorism. 2006;4(2):176-182. 
• "Removing Barriers to Global Pandemic Influenza Vaccination." Gronvall GK and Borio LL. Biosecurity and Bioterrorism. 2006;4(2):168-175. 
• "The Biological Threat to U.S. Water Supplies: Toward a National Water Security Policy." Nuzzo J. Biosecurity and Bioterrorism. 2006;4(2):147-159. 
• "Systemic Collapse: Medical Care in the Aftermath of Hurricane Katrina." Franco C, Toner E, Waldhorn R, et al. Biosecurity and Bioterrorism. 2006;4(2):135-146. 
• "Billions for Biodefense: Federal Agency Biodefense Funding, FY2006-FY2007." Lam C, Franco C, and Schuler A. Biosecurity and Bioterrorism. 2006;4(2):113-127. 
• "Control and Eradication." Miller M, Barrett S, and Henderson DA. In: Jameson DT, Breman, JG, Measham AR, et al, eds. Disease Control Priorities in Developing Countries. New York: World Bank and Oxford University Press; 2006:1163-1176. 
• "Universal Influenza Vaccination: The Time to Act is Now." Mair M, Grow RW, Mair JS, and Radonovich Jr LJ. Biosecurity and Bioterrorism. 2006;4(1):20-40. 
• "Improving Performance of HVAC Systems to Reduce Exposure to Aerosolized Infectious Agents in Buildings." Hitchcock P, Mair M, Inglesby TV, et al. Biosecurity and Bioterrorism. 2006;4(1):41-54. 
• "Do Public Health and Infection Control Measures Prevent the Spread of Flu?" Toner E. Biosecurity and Bioterrorism. 2006;4(1):84-86. 
• "The Scientific Response to a Pandemic." Gronvall GK and Henderson DA, 2006. PLoS Pathogens. 2006;2(2). 
• "Atlantic Storm." Hamilton DS and Smith BT. EMBO Reports. 2006;7:4-9. 
• "Views on Policy: Post-Katrina, Pre-pandemic America." Schoch-Spana M. Anthropology News. 2006 Jan 10;47(1). 
• "Working Group on Pandemic Influenza Preparedness: Joint Statement in Response to Department of Health and Human Services Pandemic Influenza Plan." Levi J and Inglesby TV. Clinical Infectious Diseases. 2006 Jan1;42(1):92-94. 
• "Disease Eradication and Control." Henderson DA. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious Diseases: Principles, Pathogens and Practices, Vol I. New York: Elsevier; 2006:68-72. 
• "Smallpox and Monkeypox." Henderson DA and Borio LL. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical Infectious Diseases: Principles, Pathogens and Practices, Volume I. New York: Elsevier; 2006:621-634. 

2005

• "National Strategy for Pandemic Influenza and the HHS Pandemic Influenza Plan: Thoughts and Comments." By Staff of the Center for Biosecurity of UPMC. Biosecurity and Bioterrorism. 2005;3(4):292-294. 
• "Bulls, Bears, and Birds: Preparing the Financial Industry for an Avian Influenza Pandemic." Maldin B, Inglesby TV, Nuzzo J, et al. Biosecurity and Bioterrorism. 2005;3(4):363-367. 
• "A New Role for Scientists in the Biological Weapons Convention." Gronvall GK. Nature Biotechnology. 2005; 23(10). 
• "Augmentation of Hospital Critical Care Capacity after Bioterrorist Attacks or Epidemics: Recommendations of the Working Group on Emergency Mass Critical Care." Rubinson L, Nuzzo J, Talmor DS, et al. Critical Care Medicine. 2005;33(10):2393-2403. 
• "Public Responses to Extreme Events: Top 5 Disaster Myths." Schoch-Spana M. Paper delivered at the First Wednesday Seminar, Resources for the Future. Washington, DC. October 5, 2005. 
• "Navigating the Storm: Report and Recommendations from the Atlantic Storm Exercise." Smith B, Inglesby TV, Brimmer E, et al. Biosecurity and Bioterrorism. 2005;3(3):256-267. 
• "Influenza Vaccine Scarcity 2004-05: Implications for Biosecurity and Public Health Preparedness." Schoch-Spana M, Fitzgerald J, and Kramer B. Biosecurity and Bioterrorism. 2005;3(3):224-234. 
• "Critical Care During Epidemics." Rubinson L and O'Toole T. Critical Care. 2005 Aug 9;(4):311-3. 
• "How Clean is Safe? Reopening Public Facilities after a Biological Attack." Berns K, Atlas RM, et al., July 2005. Committee on Standards and Policies for Decontaminating Public Facilities Affected by Exposure to Harmful Biological Agents: How Clean is Safe?, National Research Council. 
• "Billions for Biodefense: Federal Agency Biodefense Funding, FY2005-FY2006." Schuler A. Biosecurity and Bioterrorism. 2005;3(2):94-101. 
• "Anthrax Countermeasures: Current Status and Future Needs." Borio L and Gronvall GK. Biosecurity and Bioterrorism. 2005;3(2):102-112. 
• "Building Security: Biological Weapons Threats." Mair M. ASHRAE's IAQ Applications Spring 2005. 
• "Incidental Reflections Based on a Career in Public Health and Public Health Policy." Henderson DA. Bulletin of King County Medical Society. 2005;84:14-15. 
• "Smallpox: From Eradication to Resurrection." Henderson. Nova Acta Leopoldina. 2005;344:111-116. (Halle, Germany) 
• "The Challenge of Bio-terrorism." Hamilton DS and Brad Smith B. In: Hamilton DS, Dalgaard-Nielsen A, eds. Transatlantic Homeland Security: Protecting Society in the Age of Catastrophic Terrorism, Ch. 2. Routledge Press; 2005. 
• "Bioterrorism: An Overview." Henderson DA and Borio LL. In Mandell MD, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia, PA: Churchill Livingstone; 2005:3591-3601. 

2004

• "Strategies to Remedy Panic in a Pandemic: Lessons from Biodefense." Schoch-Spana M. In Knobler S, Mack A, Mahmoud A, Lemon SM, eds. The Threat of Pandemic Influenza: Are We Ready? – Workshop Summary. Washington, DC: National Academy of Sciences, National Academies Press. 2004;347-357. 
• "Taking the Measure of Countermeasures: Leaders' Views on the Nation's Capacity to Develop Biodefense Countermeasures." Gilfillan L, Smith B, Inglesby TV, et al. Biosecurity and Bioterrorism. 2004;2(4):320-327. 
• "Executive Government Positions of Influence in Biodefense: The Bio-Plum Book." Schuler A, Fitzgerald J, Inglesby TV, and O'Toole T. Biosecurity and Bioterrorism. 2004;2(4):328-341. 
• "The Threat of Biological Weapons." Henderson DA. ASHRAE Journal. 2004 Dec; 46(12):34-37. 
• "Bioterrorism: U.S. Public Health and a Secular Apocalypse." Schoch-Spana M. Anthropology Today. 2004 Oct 1;20(5):1-6. 
• "Biodefense -- If Risk Communication is the Answer, What is the Question?" Schoch-Spana M. Natural Hazards Observer. 2004;29(1):1-3. 
• "The Biosecurity of Nations." Smith B. Foreign Policy. 2004 Jul/Aug:87-88. 
• "Smallpox Vaccine." Henderson DA. In de Quadros CA , ed. Vaccines: Preventing Disease and Protecting Health. Washington, DC: Pan American Health Organization; 2004:281-286. 
• "Billions for Biodefense: Federal Agency Biodefense Funding, FY2001-FY2005." Schuler A. Biosecurity and Bioterrorism. 2004;2(2):86-96. 
• "Leading During Bioattacks and Epidemics with the Public's Trust and Help." By Working Group on 'Governance Dilemmas'. Biosecurity and Bioterrorism. 2004;2(1):25-40. 
• "Psychosocial Consequences of a Catastrophic Outbreak of Disease." Schoch-Spana M. In: Ursano R, Fullerton C, Norwood A, eds. Bioterrorism: Psychological and Public Health Interventions. Cambridge: Cambridge University Press; 2004:38-55. 

2003

• "A Complementary Approach to Bioterrorism Prevention." Mair M and Mair JS. Nonproliferation Review. 2003;10(3):114-124. 
• "Inhalational Anthrax: Radiologic and Pathologic Findings in Two Cases." Wood BJ, DeFranco B, Ripple M, et al. American Journal of Roentgenology. 2003;181(4):1071-1078. 
• "Vaccine Liability in the Era of Bioterrorism." Mair JS and Mair M. Biosecurity and Bioterrorism. 2003;1(3):169-184. 
• "The Challenge of Hospital Infection Control During a Response to Bioterrorist Attack." Grow R and Rubinson L. Biosecurity and Bioterrorism. 2003;1(3):215-220. 
• "Biodefense R&D: Anticipating Future Threats, Establishing a Strategic Environment." Smith B, Inglesby TV, and O'Toole T. Biosecurity and Bioterrorism. 2003;1(3):193-202. 
• "Smallpox Vaccination (vaccinia) A Review." Fulginiti VA, Papier A, Lane JM, et al. Clinical Infectious Diseases. 2003;37(2):241-50. 
• "Smallpox Vaccination (vaccinia) A Review, Part II Adverse Events." Fulginiti VA, Papier A, Lane JM, et al., July 2003. Clinical Infectious Diseases. 2003;37(2):251-271. 
• "Battling Infectious Diseases." O'Toole T and Inglesby TV. Washington Times. 2003 Jul 9;A21. 
• "Public Health Preparedness." Henderson DA. In: Teich AH, Nelson SD, et al., eds. Science and Technology in a Vulnerable World: A Special Supplement to the 2003 AAAS Science and Technology Policy Yearbook. 2003:33-40. 
• "Beyond Pacification and a Panicked Public: New Principles for Bioterrorism Preparedness and Response." Schoch-Spana M. PA Times (American Society for Public Administration). 2003;26(2):9-10. 
• "Anthrax 2001: Observations on the Medical and Public Health Response." Gursky E, Inglesby TV, and O'Toole T. Biosecurity and Bioterrorism. June 2003;1(2):97-110. 
• "Commentary on Dr. Zelicoff's Epidemiological Analysis of the Aralsk Outbreak." Henderson DA. Critical Reviews in Microbiology. 2003;29(2):169-170. 
• "Smallpox Vaccination in 2003: Key Information for Clinicians." Bartlett J, Borio L, Radonovich L, et al. Clinical Infectious Diseases. 2003;36(7):883-902 
• "Biosecurity: Responsible Stewardship of Bioscience in an Age of Catastrophic Terrorism." Kwik G, Fitzgerald J, Inglesby TV, and O'Toole T. Biosecurity and Bioterrorism. 2003;1(1):27-35. 
• "Key Information Regarding Smallpox Vaccine." Mair M and Borio L. Biosecurity and Bioterrorism. 2003;1(1):53-54. 
• "Toward Biosecurity." O'Toole T and Inglesby TV. Biosecurity and Bioterrorism. 2003;1(1):1-3. 
• "I Was Vaccinated Against Smallpox 40 Years Ago. Am I Still Protected?" Kwik G. Scientific American Online. 2003 Mar 3. 
• "Statement on Scientific Publication and Security." Atlas R, Campbell P, Cozzarelli NR, Curfman G, Enquist L, Fink G, Flanagin A, Fletcher J, George E, Hammes G, Heyman D, Inglesby TV, et al. Science. 2003 Feb 21; 299(5610):1149. 
• "Bioscientists, Bioterrorism, and National Security." Smith BT. Science NextWave. 2003 Feb 14. 
• "CPTED and Public Health: A Natural Partnership." Mair JS and Mair M. The CPTED Journal. 2003;2(1):21-33. 
• "Smallpox and Vaccinia." Henderson DA, Borio LL and Lane JM. In: Plotkin S, Orenstein W, eds. Vaccines. Philadelphia, PA: WB Saunders Company; 2003:123-153. 
• "Educating, Informing and Mobilizing the Public." Schoch-Spana M. In: Levy B, Sidel V, eds. Terrorism and Public Health. Oxford University Press; 2003:118-135. 

2002

• "Contact Vaccinia--Transmission of Vaccinia from Smallpox Vaccination." Neff JM, Lane JM, Fulginiti VA, and Henderson DA. The Journal of the American Medical Association. 2002;288(15):1901-1905. 
• "Management of Anthrax." Bartlett J, Inglesby TV, and Borio L. Clinical Infectious Diseases. 2002 Oct 1;35(7):851-8. 
• "The Hemorrhagic Fever Viruses as Biological Weapons: Medical and Public Health Management." Borio L, Inglesby TV, Peters CJ, et al. The Journal of the American Medical Association. 2002;287(18):2391-2405. 
• "Anthrax as a Biological Weapon, 2002: Updated Recommendations for Management." Inglesby TV, O’Toole T, Henderson DA, et al. The Journal of the American Medical Association. 2002;287(17):2236-2252. 
• "Current Concepts: Smallpox Diagnosis and Management." Breman JG and Henderson DA. New England Journal of Medicine. 2002;346: 1300-1308. 
• "Shining Light on 'Dark Winter'." O’Toole T, Mair M, and Inglesby TV. Clinical Infectious Diseases. 2002;34(7):972-983. 
• "Bioterrorism and the People: How to Vaccinate a City against Panic." Glass T and Schoch-Spana M. Clinical Infectious Diseases. 2002;34(2):217:223. 
• "Anthrax for the Pulmonary Physician, Pulmonary and Critical Care Update - Online." Bartlett J, Inglesby TV, and Borio L. Pulmonary and Critical Care Update - Online. 16:Lesson 1. 2002. 
• "Countering the Post Eradication Threat of Smallpox and Polio." Henderson DA. Clinical Infectious Diseases. 2002;34(1):79-83. 
• "Bioterrorism--Guidelines for Medical and Public Health Management." Henderson DA, Inglesby TV, and O’Toole T. Chicago, IL: The Journal of the American Medical Association & Archives Journals; 2002 Jul. 
• "Bioterrorism and Public Health." O’Toole T, Inglesby TV, Bartlett J, and Mair M. 2002: eMedguides.com. 

2001

• "Letter to the Editor: Biopreparedness and Public Health." Henderson DA. American Journal of Public Health. 2001;91(12): 1917-1918. 
• "Large-scale Quarantine Following Biological Terrorism in the United States: Scientific Examination, Logistic and Legal Limits, and Possible Consequences." J. Barbera, A. Macintyre, L. Gostin, Inglesby TV, et al. The Journal of the American Medical Association. 2001;286(21). 
• "Death Due to Bioterrorism-related Inhalational Anthrax: Report of 2 Patients." Borio L, D. Frank, V. Mani, et al. The Journal of the American Medical Association. 2001;286(20):2554-2559. 
• "Recent Events and Observations Pertaining to Smallpox Virus Destruction in 2002." Henderson DA and Fenner F. Clinical Infectious Diseases. 2001;33(7):1057-1059. 
• "Anthrax and Plague." Inglesby TV. In: Scheld WM, Craig WA, Hughes JM, eds. Emerging Infections 5. American Society of Microbiology Press. 2001 Sept 11. 
• "The Problem of Biological Weapons: Next Steps for the Nation." O’Toole T. Public Health Reports. 2001;116(Suppl 2):108-111. 
• "Observations from the TOPOFF Exercise." Inglesby TV. Public Health Reports. 2001;116(Suppl 2):64-68. 
• "Hospitals 'Full-up': The 1918 Influenza Pandemic." Schoch-Spana M. Public Health Reports. 2001;116(Suppl 2):32-33. 
• "Epidemic Response Scenario: Decision-making in a Time of Plague." O’Toole T and Inglesby TV. Public Health Reports. 2001;116 (Suppl 2):92-103. 
• "A Clearly Present Danger: Confronting the Threat of Bioterrorism." O’Toole T and Henderson DA. Harvard International Forum. 2001;23:49-53. 
• "Emerging Illness and Bioterrorism: Implications for Public Health." O’Toole T. Journal of Urban Health. 2001;78(2):396-402. 
• "The Statistical Analysis of Truncated Data: Application to the Sverdlovsk Anthrax Outbreak." Brookmeyer R, Blades N, Hugh-Jones M, and Henderson DA. Biostatistics. 2001;2(2):233-247. 
• "Tularemia as a Biological Weapon: Medical & Public Health Management." Dennis DT, Inglesby TV, Hayes EB, et al. The Journal of the American Medical Association. 2001;285(21):2763-2773. 
• "Botulinum Toxin as a Biological Weapon: Medical & Public Health Management." Arnon SS, Schechter R, Inglesby TV, et al. The Journal of the American Medical Association. 2001;285(8):1059-1070. 
• "A Plague on Your City: Observations from TOPOFF." Inglesby TV, Grossman R, and O’Toole T. Clinical Infectious Diseases. 2001;32(3):436-445. 
• "Facing the Biological Weapons Threat." O’Toole T and Inglesby TV. The Lancet. 2001;(357):1128 (Editorial). 
• "Smallpox and Monkeypox." Henderson DA. In: Guerant RL, Walker DH, Weller PF, eds. Essentials of Tropical Infectious Diseases. Philadelphia, PA: WB Saunders; 2001:519-524. 
• "Medical Aspects of Biological Terrorism." Inglesby TV and O’Toole T. Medical Knowledge and Self-Assessment Program (MKSAP), American College of Physicians. 12th Edition. 2001. 
• "Medical and Public Health Threats Posed by Biological Weapons." Inglesby TV. In: Alexander Y, Prior S. Terrorism and Medical Responses: U.S. Lessons and Policy Implications. Ardsley, NY: Transnational Publishers. 2001. 

2000

• "Bioterrorism." Henderson DA. International Journal of Clinical Practice. 2000;Dec, (115):32-6. 
• "Implications of Pandemic Influenza for Bioterrorism Response." Schoch-Spana M. Clinical Infectious Diseases. 2000;31(6):1409-1413. 
• "Safety Precautions to Limit Exposure to Plague-infected Patients." Inglesby TV, Henderson DA, O’Toole T, and Dennis D. The Journal of the American Medical Association. 2000 Oct 4; 284(13):1648-9. 
• "Book Review: The Woman Who Knew Too Much." O’Toole T. Bulletin of the Atomic Scientists. 2000 Jul-Aug. 
• "Preventing the Use of Biological Weapons: Improving Response Should Prevention Fail." Inglesby TV, O’Toole T, and Henderson DA. Clinical Infectious Diseases. 2000;30(6):926-929. 
• "Plague as a Biological Weapon: Medical and Public Health Management." Inglesby TV, Dennis DT, and Henderson DA, May 2000. The Journal of the American Medical Association. May 3, 2000;283(17):2281-2290. 
• "Smallpox: Public Health Threat." Henderson DA, January 2000. Encyclopedia of Life Sciences, 2nd Edition. Macmillan Reference Limited. 2000;Article 3368. 
• "Smallpox Eradication." Henderson DA. Encyclopedia of Life Sciences, 2nd Edition. Macmillan Reference Limited. 2000:Article 959. 

1999

• "Recognition and Treatment of Anthrax." Inglesby TV and Henderson DA. The Journal of the American Medical Association. 1999 Nov 3; 283(17):1625. 
• "Lessons from the Eradication Campaigns." Henderson DA. Vaccine. 1999;17(Supp 3):553-557. 
• "Smallpox: Clinical and Epidemiological Features." Henderson DA. Emerging Infectious Diseases. 1999;5(4):537-539. 
• "Smallpox: An Attack Scenario." O’Toole T. Emerging Infectious Diseases. 1999; 5(4):540-546. 
• "Anthrax: A Possible Case History." Inglesby TV. Emerging Infectious Diseases. 199;5(4):556-560. 
• "Smallpox Eradication--A Cold War Victory." Henderson DA. World Health Forum. 1999;19:113-119. 
• "Smallpox as a Biological Weapon: Medical and Public Health Management." Henderson DA, Inglesby TV, and Bartlett JG. The Journal of the American Medical Association. 1999;281(22):2127-2137. 
• "Anthrax as a Biological Weapon: Medical and Public Health Management." Inglesby TV, Henderson DA, and Bartlett JG. The Journal of the American Medical Association. 1999;281(18):1735-1745. 
• "The Looming Threat of Bioterrorism." Henderson DA. Science. 1999;283(5406):1279-1282. 
• "Weapons for the Future." Henderson DA. The Lancet. 1999;354 (Supplement 4):siv 64. 
• "Smallpox and Vaccinia." Henderson DA. In: Plotkin S and Orenstein W, eds. Vaccines. Philadelphia, PA: WB Saunders Company; 1999:74-97. 
• "Disease Eradication and Control." Henderson DA. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical Infectious Diseases: Principles, Pathogens and Practices, Volume I. Edinburgh: Churchill Livingstone; 1999:101-105. 
• "Smallpox and Monkeypox." Henderson DA. In: Guerrant RL,Walker DH & Weller PF, eds. Tropical Infectious Diseases: Principles, Pathogens and Practices, Volume II. Edinburgh: Churchill Livingstone; 1999:1095-1106. 
• "Smallpox." Henderson DA. In: Lederberg J, ed. Encyclopedia of Microbiology, 2nd Edition, Volume 4. Academic Press; 1999:289-296. 

1998

• "Germs of War." Inglesby TV. The Washington Post. 1998 Dec 9:H01. 
• "Bioterrorism as a Public Health Threat." Henderson DA. Emerging Infectious Diseases. 1998;4(3):488-492. 
• "The Siren Song of Eradication." Henderson DA. Journal of the Royal College of Physicians. 1998;32:580-584. 
• "The Challenge of Eradication: Lessons from Past Eradication Campaigns." Henderson DA. The International Journal of Tuberculosis and Lung Disease. 1998;2(9):54-58. 

Go to: 2012 | 2011 | 2010 | 2009 | Publications archive